13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • RAPPER

    Acronym: 

    RAPPER

    ACTRN/NCT /ethics: 

    Scientific title: 

    REVIEW OF AUSTRALIAN PRESCRIBING PRACTICES OF ERIBULIN

    Summary of trial and patient characteristics

    Cancer Type All cancers
    Trial Type Early detection, diagnosis, prognosis
    Phase All phases Tumour Stream Registry/database
    Age Range Cancer Stage All stages
    Sex Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type All cancers
    Trial Type Early detection, diagnosis, prognosis
    Phase All phases
    Age Range
    Sex
    Molecular Target
    Tumour Stream Registry/database
    Cancer Stage All stages
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    REVIEW OF AUSTRALIAN PRESCRIBING PRACTICES OF ERIBULIN

    Lay Summary

    REVIEW OF AUSTRALIAN PRESCRIBING PRACTICES OF ERIBULIN

    Sponsor / Cooperative group

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Ashford Cancer Centre Research Sue Yeend syeend@adelaidecancercentre.com.au 08 8292 2240 Dr Kerry Cheong Recruiting